Medicine and Dentistry
Adenocarcinoma
10%
Biological Marker
6%
Biopsy Technique
6%
Bladder
6%
Bladder Tumor
11%
Breast Cancer
9%
Breast Carcinoma
9%
Cancer
11%
Carcinogenesis
6%
Cell Therapy
9%
Clear Cell
6%
Clear Cell Renal Cell Carcinoma
30%
Comprehensive Genomic Profiling
8%
Connective Tissue Cancer
7%
Cystectomy
12%
Diseases
19%
Effusion
7%
Gene Expression
10%
Gleason Score
7%
Immunohistochemistry
14%
Kidney Cancer
9%
Kidney Metastasis
7%
Kidney Sarcoma
10%
Kidney Tumour
20%
Malignant Neoplasm
20%
microRNA
9%
Needle Biopsy
18%
Neoplasm
100%
Non Small Cell Lung Cancer
14%
Oncocytoma
7%
Overall Survival
6%
Oxidative Stress
9%
Partial Nephrectomy
9%
Pleckstrin Homology Domain
9%
Progenitor Cell
9%
Prostate Cancer
27%
Prostatectomy
9%
Radiation Therapy
7%
Radical Nephrectomy
10%
Recurrent Disease
16%
Surgical Margin
9%
Surgical Technique
8%
Tissue Microarray
27%
Transitional Cell Carcinoma
11%
Tumor Infiltrating Lymphocyte
9%
Tumor Xenograft
12%
Uvomorulin
6%
Vaginal Ultrasonography
6%
Wilms' Tumor
32%
Xenograft
7%
Keyphrases
Adoptive Cell Therapy
9%
AKT1
10%
Bladder Tumor
9%
Cancer Patients
8%
Chemotherapy
15%
Comprehensive Genomic Profiling
8%
Confidence Interval
8%
Consensus Conference
8%
Core Needle Biopsy
15%
Discoidin Domain Receptor 1 (DDR1)
8%
DVL1
8%
EMP1
8%
En Bloc Resection
9%
Histological Subtypes
7%
Histology
7%
Immunohistochemical Expression
9%
Immunohistochemical Markers
8%
Immunohistochemical Study
9%
Immunohistochemistry
11%
International Society of Urological Pathology
11%
Invasive Breast Carcinoma
9%
Local Recurrence
9%
Microarray Profiling
14%
MicroRNA
11%
Neoplasms
11%
Non-small Cell Lung Cancer (NSCLC)
20%
Oncocytoma
8%
Oncological Outcomes
13%
Ovarian Tissue
7%
Overall Survival
8%
Oxidative Stress
9%
Pleckstrin Homology Domain
9%
Prognostic Value
9%
Prostate
10%
Prostate Cancer
25%
Radical Cystectomy
8%
Radical Nephrectomy
10%
Radical Prostatectomy
8%
Renal Cancer
13%
Renal Cell Carcinoma
29%
Renal Sarcoma
10%
Renal Tumor
13%
Tissue Microarray
32%
Transurethral Resection of Bladder Tumor (TURBT)
10%
Tumor
57%
Tumor Xenograft
11%
Tumor-infiltrating Lymphocytes
9%
Wilms Tumor
32%
Zinc
9%
Zinc Concentration
14%